Provided By GlobeNewswire
Last update: Apr 9, 2025
Successful robotic navigation was achieved in every case and met the primary endpoint of the study
LIBERTY® showed a 92% reduction in radiation exposure with no adverse events reported
Read more at globenewswire.comNASDAQ:MBOT (6/18/2025, 9:47:16 AM)
2.4578
+0.04 (+1.56%)
Find more stocks in the Stock Screener